A once-a-day tablet for advanced breast cancer will be rolled out on the NHS. More than 1,000 women will be eligible for the drug elacestrant after a U-turn by the National Institute for Health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback